Abstract
Introduction: The aim of this study was to investigate the effect of TURP on erectile function (EF) and ejaculatory function (EJF). Methods: A total of 91 patients who underwent TURP were retrospectively assessed. Patients were divided into two groups based on International Index of Erectile Function (IIEF-5): group A included 41 patients with normal EF, and group B included 50 patients with erectile dysfunction (ED). All patients were evaluated for EF and EJF at baseline, 1, 3, and 6 months after TURP by using IIEF-5, Ejaculatory Domain-Male Sexual-Health Inventory (Ej-MSHQ). Results: In group A, there were no significant statistical differences in mean IIEF-5 at baseline and after TURP 22.88 ± 0.81 versus 22.63 ± 2.63 (p = 0.065). However, in group B, there was significant improvement in IIEF-5 after TURP all over the follow-up time points in comparison to the baseline (p = <0.001). The loss of EJF was significant among patients in group A. There was significant improvement of IPSS and Qmax in group A after surgery compared to group B. Conclusion: The results confirmed that TURP has no significant negative influence on EF, and patients with preexisting ED were improved after TURP. On the contrary, the loss of EJF was significant.
References
1.
Gratzke
C
, Bachmann
A
, Descazeaud
A
, Drake
MJ
, Madersbacher
S
, Mamoulakis
C
, EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction
. Eur Urol
. 2015
;67
(6
):1099
–109
.2.
Vuichoud
C
, Loughlin
KR
. Benign prostatic hyperplasia: Epidemiology, economics and evaluation
. Can J Urol
. 2015
;22
(Suppl 1
):1
–6
.3.
Köhler
TS
, McVary
KT
. The relationship between erectile dysfunction and lower urinary tract symptoms and the role of phosphodiesterase type 5 inhibitors
. Eur Urol
. 2009
;55
(1
):38
–48
.4.
Şahin
B
, Çam
HK
. The current approach to male patients with lower urinary tract symptoms
. J Urol Surg
. 2021
;8
(2
):130
–4
.5.
Gravas
S
, Cornu
JN
, Gacci
M
, Gratzke
C
, Herrmann
TRW
, Mamoulakis
C
, EAU guidelines on management of non-neurogenic male lower urinary tract symptoms (LUTS), incl. Benign prostatic obstruction (BPO)
. 2020
.6.
Lerner
LB
, McVary
KT
, Barry
MJ
, Bixler
BR
, Dahm
P
, Das
AK
, Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline part II: surgical evaluation and treatment
. J Urol
. 2021 Oct
;206
(4
):818
–26
.7.
Becher
EF
, McVary
KT
. Surgical procedures for BPH/LUTS: Impact on male sexual health
. Sex Med Rev
. 2014
;2
(1
):47
–55
. .8.
Enikeev
D
, Glybochko
P
, Rapoport
L
, Okhunov
Z
, O’Leary
M
, Potoldykova
N
, Impact of endoscopic enucleation of the prostate with thulium fiber laser on the erectile function
. BMC Urol
. 2018
;18
(1
):1
–6
.9.
Oka
AAG
, Duarsa
GWK
, Novianti
PA
, Mahadewa
TGB
, Ryalino
C
. The impact of prostate-transurethral resection on erectile dysfunction in benign prostatic hyperplasia
. Res Rep Urol
. 2019
;11
:91
–6
. .10.
Borchert
A
, Leavitt
DA
. A review of male sexual health and dysfunction following surgical treatment for benign prostatic hyperplasia and lower urinary tract symptoms
. Curr Urol Rep
. 2018
;19
(8
):66
. .11.
Rieken
M
, Antunes-Lopes
T
, Geavlete
B
, Marcelissen
T
. What is new with sexual side effects after transurethral male lower urinary tract symptom surgery?
Eur Urol Focus
. 2018
;4
(1
):43
–5
. .12.
Li
Z
, Chen
P
, Guo
Y
, Xiang
H
, Mao
Q
, Zeng
G
, The impact of surgical treatments for lower urinary tract symptoms/benign prostatic hyperplasia on male erectile function: a systematic review and network meta-analysis
. J Sex Med
. 2017
;14
(1
):S50
–1
.13.
Muntener
M
, Aellig
S
, Kuettel
R
, Gehrlach
C
, Sulser
T
, Strebel
RT
. Sexual function after transurethral resection of the prostate (TURP): results of an independent prospective multicentre assessment of outcome
. Eur Urol
. 2007
;52
(2
):510
–5
. .14.
McMahon
CG
, Abdo
C
, Incrocci
L
, Perelman
M
, Rowland
D
, Waldinger
M
, Disorders of orgasm and ejaculation in men
. J Sex Med
. 2004
;1
(1
):58
–65
.15.
Sturch
P
, Woo
HH
, McNicholas
T
, Muir
G
. Ejaculatory dysfunction after treatment for lower urinary tract symptoms: retrograde ejaculation or retrograde thinking?
BJU Int
. 2015
;115
(2
):186
–7
. .16.
El-Assmy
A
, ElShal
AM
, Mekkawy
R
, El-Kappany
H
, Ibrahiem
EHI
. Erectile and ejaculatory functions changes following bipolar versus monopolar transurethral resection of the prostate: a Prospective Randomized Study
. Int Urol Nephrol
. 2018
;50
(9
):1569
–76
. .17.
Mamoulakis
C
, Skolarikos
A
, Schulze
M
, Scoffone
CM
, Rassweiler
JJ
, Alivizatos
G
, Bipolar vs monopolar transurethral resection of the prostate: evaluation of the impact on overall sexual function in an international randomized controlled trial setting
. BJU Int
. 2013 Jul
;112
(1
):109
–20
.18.
Elshal
AM
, Elmansy
HM
, Elkoushy
MA
, Elhilali
MM
. Male sexual function outcome after three laser prostate surgical techniques: a single center perspective
. Urology
. 2012 Nov 1
;80
(5
):1098
–104
. .19.
Akman
T
, Binbay
M
, Tekinarslan
E
, Tepeler
A
, Akcay
M
, Ozgor
F
, Effects of bipolar and monopolar transurethral resection of the prostate on urinary and erectile function: a Prospective Randomized Comparative Study
. BJU Int
. 2013
;111
(1
):129
–36
.20.
Bruyère
F
, Puichaud
A
, Pereira
H
, Faivre d’Arcier
BF
, Rouanet
A
, Floc’h
AP
, Influence of photoselective vaporization of the prostate on sexual function: results of a prospective analysis of 149 patients with long-term follow-up
. Eur Urol
. 2010 Aug 1
;58
(2
):207
–11
.21.
Mishriki
SF
, Grimsley
SJS
, Lam
T
, Nabi
G
, Cohen
NP
. TURP and sex : Patient and Partner Prospective 12 Years Follow-Up Study
. BJU Int
. 2012 Mar
;109
(5
):745
–50
.22.
Poulakis
V
, Ferakis
N
, Witzsch
U
, de Vries
R
, Becht
E
. Erectile dysfunction after transurethral prostatectomy for lower urinary tract symptoms: results from a center with over 500 patients
. Asian J Androl
. 2006
;8
(1
):69
–74
. .23.
Elshal
AM
, El-Assmy
A
, Mekkawy
R
, Taha
DE
, El-Nahas
AR
, Laymon
M
, Prospective controlled assessment of men’s sexual function changes following Holmium laser enucleation of the prostate for treatment of benign prostate hyperplasia
. Int Urol Nephrol
. 2017
;49
(10
):1741
–9
.24.
Jaidane
M
, Arfa
NB
, Hmida
W
, Hidoussi
A
, Slama
A
, Sorba
NB
, Effect of transurethral resection of the prostate on erectile function: a Prospective Comparative Study
. Int J Impot Res
. 2010
;22
(2
):146
–51
.25.
Capogrosso
P
, Ventimiglia
E
, Ferrari
M
, Serino
A
, Boeri
L
, Capitanio
U
, Long-term sexual outcomes after holmium laser enucleation of the prostate: Which patients could benefit the most?
Int J Impot Res
. 2016
;28
(5
):189
–93
.26.
Hanbury
DC
, Sethia
KK
. Erectile function following transurethral prostatectomy
. Br J Urol
. 1995 Jan
;75
(1
):12
–3
. .27.
Choi
SB
, Zhao
C
, Park
JK
. The effect of transurethral resection of the prostate on erectile function in patients with benign prostatic hyperplasia
. Korean J Urol
. 2010
;51
(8
):557
–60
. .28.
Marra
G
, Sturch
P
, Oderda
M
, Tabatabaei
S
, Muir
G
, Gontero
P
. Systematic review of lower urinary tract symptoms/benign prostatic hyperplasia surgical treatments on men’s ejaculatory function: Time for a bespoke approach?
Int J Urol
. 2016
;23
(1
):22
–35
.29.
Ahyai
SA
, Gilling
P
, Kaplan
SA
, Kuntz
RM
, Madersbacher
S
, Montorsi
F
, Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement
. Eur Urol
. 2010
;58
(3
):384
–97
.© 2022 S. Karger AG, Basel
2022
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
